文献速递乳腺癌胸部肿瘤

2019年欧洲癌症死亡率预测:聚焦乳腺癌

European cancer mortality predictions for the year 2019 with focus on breast cancer.
PubMed 文献 · Ann Oncol · 2019-01-01

该研究基于世界卫生组织与欧盟统计局1970-2014年数据,预测2019年欧盟癌症死亡约141万例,男性年龄标化率130.9/10万(较2014年下降5.9%),女性82.9/10万(下降3.6%)。乳腺癌死亡率在多数国家下降,50-69岁女性降幅最大(16.4%),但人口老龄化使乳腺癌死亡绝对数未下降。

要点

  • 2019年欧盟预测癌症死亡约141万例,男性年龄标化率130.9/10万(较2014年下降5.9%),女性82.9/10万(下降3.6%)。
  • 女性肺癌率2014-2019年预计上升4.4%至14.8/10万,乳腺癌预测率为13.4/10万。
  • 乳腺癌死亡率在50-69岁女性下降16.4%,20-49岁下降13.8%,70-79岁下降6.1%。

核心结论

  • 2014至2019年间男女癌症死亡率均将持续下降,乳腺癌率稳步下降,近三十年降幅约35%。
  • 乳腺癌死亡率下降可能归因于激素替代治疗使用减少、筛查改进、早期诊断和治疗进步。
  • 由于人口老龄化,乳腺癌死亡绝对数并未下降。

研究设计与样本

  • 从世界卫生组织与欧盟统计局数据库检索1970-2014年癌症死亡证明和人口数据。
  • 采用对数泊松连接点回归模型识别最近趋势期,再以线性回归估计2019年死亡数和率。
  • 计算1989-2019年期间避免的死亡数。

主要发现

  • 2019年欧盟估计约141万例癌症死亡,男性年龄标化率130.9/10万(较2014年下降5.9%),女性82.9/10万(下降3.6%)。
  • 女性肺癌率2014至2019年预计上升4.4%,达到14.8/10万;乳腺癌预测率为13.4/10万。
  • 除胰腺癌外,主要肿瘤的有利趋势预计持续。
  • 六个考察国家中除波兰外乳腺癌死亡率趋势均有利;50-69岁女性降幅最大(下降16.4%),20-49岁下降13.8%,70-79岁下降6.1%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To overcome the lag with which cancer statistics become available, we predicted numbers of deaths and rates from all cancers and selected cancer sites for 2019 in the European Union (EU). MATERIALS AND METHODS: We retrieved cancer death certifications and population data from the World Health Organization and Eurostat databases for 1970-2014. We obtained estimates for 2019 with a linear regression on number of deaths over the most recent trend period identified by a logarithmic Poisson joinpoint regression model. We calculated the number of avoided deaths over the period 1989-2019. RESULTS: We estimated about 1 410 000 cancer deaths in the EU for 2019, corresponding to age-standardized rates of 130.9/100 000 men (-5.9% since 2014) and 82.9 women (-3.6%). Lung cancer trends in women are predicted to increase 4.4% between 2014 and 2019, reaching a rate of 14.8. The projected rate for breast cancer was 13.4. Favourable trends for major neoplasms are predicted to continue, except for pancreatic cancer. Trends in breast cancer mortality were favourable in all six countries considered, except Poland. The falls were largest in women 50-69 (-16.4%), i.e. the age group covered by screening, but also seen at age 20-49 (-13.8%), while more modest at age 70-79 (-6.1%). As compared to the peak rate in 1988, over 5 million cancer deaths have been avoided in the EU over the 1989-2019 period. Of these, 440 000 were breast cancer deaths. CONCLUSION: Between 2014 and 2019, cancer mortality will continue to fall in both sexes. Breast cancer rates will fall steadily, with about 35% decline in rates over the last three decades. This is likely due to reduced hormone replacement therapy use, improvements in screening, early diagnosis and treatment. Due to population ageing, however, the number of breast cancer deaths is not declining.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Malvezzi M, Carioli G, Bertuccio P, et al. European cancer mortality predictions for the year 2019 with focus on breast cancer. Ann Oncol. 2019. PMID: 30887043. doi:10.1093/annonc/mdz051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。